Carrier-free nanodrug: A novel strategy of cancer diagnosis and synergistic therapy

被引:94
|
作者
Yang, Ming-Yue [1 ]
Zhao, Rui-Rui [1 ]
Fang, Yi-Fan [1 ]
Jiang, Jia-Li [1 ]
Yuan, Xiao-Tian [1 ]
Shao, Jing-Wei [1 ,2 ]
机构
[1] Fuzhou Univ, Coll Chem, Fujian Prov Key Lab Canc Metastasis Chemoprevent, Fuzhou 350116, Fujian, Peoples R China
[2] Minjiang Univ, Marine Drug R&D Ctr, Inst Oceanog, Fuzhou 350108, Fujian, Peoples R China
基金
中国国家自然科学基金;
关键词
Carrier-free; Nanodrug; Self-assembly; Synergistic cancer therapy; MESOPOROUS SILICA NANOPARTICLES; DUAL ANTICANCER DRUGS; PHOTODYNAMIC THERAPY; SELF-DELIVERY; IN-VITRO; TARGETED THERAPY; HIGHLY EFFICIENT; CO-DELIVERY; TUMOR; PRODRUG;
D O I
10.1016/j.ijpharm.2019.118663
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nanoformulations with advantages in drug delivery, safety and pharmacodynamics have been booming as a promising strategy for cancer therapy. However, the traditional nanocarrier still suffers from the low drug loading capacity, potential systematic toxicity, unclear metabolism, and other uncertainties. To overcome these issues, carrier-free nanodrugs with desirable bioactivity were developed rapidly and drawn considerable attention. Meanwhile, the multifunctional self-delivery nanoarcheticture fabricated by a simple and "green" method, has significant advantages in synergistic cancer therapy and inhibition of multidrug resistant (MDR). Till now, carrier-free nanoparticles for tumor theranostics, phototherapy, chemotherapy, diagnose and synergistic therapy, have made outstanding progress. In this review, we make an integrated and exhaustive overview of lately reports on carrier-free nanodrug delivery systems formed by several active agents. We summarize the self-assembly and modified strategies, with emphasis on application superiority of carrier-free nanocrystal, and give new insight into the establishment of ideal nanosystems for cancer treatment.
引用
收藏
页数:13
相关论文
empty
未找到相关数据